GLYCOBOND
Glycobond develops and produces proprietary carbohydrate-binding reagents for use in diagnostics. Glycobond has developed HepaCheC™, an ELISA-based assay that detects aberrant and cancer-specific glycosylation on alpha-1 acid glycoprotein (AGP), an acute phase plasma protein produced mainly in the liver. The protein is secreted into the blood stream why analysis can be performed on a simple blood sample. The method is based on a patented fucose-binding protein, Mono-F, and has shown very promising results in longitudinal analyses of serum samples from patients at risk of developing HCC.
GLYCOBOND
Industry:
Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Linköping, Ostergotlands Lan, Sweden
Country:
Sweden
Website Url:
http://www.glycobond.com
Total Employee:
1+
Status:
Active
Total Funding:
59.47 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Apache Japanese Yen Helix Ultimate
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Glycobond
LIU Invest
LIU Invest investment in Venture Round - Glycobond
Almi Invest
Almi Invest investment in Venture Round - Glycobond
Official Site Inspections
http://www.glycobond.com
- Host name: 137.220.242.216
- IP address: 137.220.242.216
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
